SAM protects against alveolar septal cell apoptosis in autoimmune emphysema rats

Dan Li1,2, Ben-Xue Li1,3, Ye Zhang1,2

  • 1Department of Respiratory Medicine, Guizhou Provincial People's Hospital, No. 83, Zhongshan East Road, Guiyang, Guizhou, China.

PubMed
Abstract

Insights

S-adenosylmethionine (SAM) treatment reduced alveolar septal cell apoptosis and inflammation in rats with autoimmune emphysema. SAM may protect by reversing perforin gene hypomethylation in CD4+ T cells.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Molecular Biology

Background:

  • Autoimmune emphysema in rats involves CD4+ T cell perforin gene promoter hypomethylation, inflammation, and oxidative stress, leading to alveolar septal cell apoptosis.
  • S-adenosylmethionine (SAM) is investigated for its potential therapeutic effects on these pathological processes.

Purpose of the Study:

  • To investigate the effects of SAM on alveolar septal cell apoptosis in rats with experimentally induced autoimmune emphysema.
  • To explore the potential role of perforin gene promoter methylation in CD4+ T cells as a mechanism of SAM's action.

Main Methods:

  • Twenty-four rats were divided into normal control, model (autoimmune emphysema), and SAM treatment groups.
  • Evaluated lung pathology, mean linear intercept (MLI), mean alveolar number (MAN), serum anti-endothelial cell antibodies (AECA), alveolar septal cell apoptosis, and perforin gene promoter methylation in CD4+ T cells.
  • Assessed cytokines (TNF-α, MMP-9, IL-8), malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) in bronchoalveolar lavage fluid (BALF).

Main Results:

  • The model group showed increased MLI, apoptosis index, AECA, TNF-α, MMP-9, MDA, and IL-8, with decreased MAN, perforin gene methylation, GSH, SOD, and GSH-Px compared to controls (P<0.05).
  • SAM treatment significantly improved these parameters, bringing them closer to normal control levels.
  • SAM group exhibited reduced apoptosis, inflammation, and oxidative stress markers compared to the model group.

Conclusions:

  • SAM demonstrates protective effects against alveolar septal cell apoptosis, airway inflammation, and oxidative stress in autoimmune emphysema models.
  • These protective effects are potentially mediated by the partial reversal of perforin gene promoter hypomethylation in CD4+ T cells.
  • SAM represents a potential therapeutic agent for autoimmune emphysema.